Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Senti Biosciences (SNTI) just unveiled an announcement.
Senti Biosciences, Inc. has announced significant changes in its executive team: Timothy Lu, the CEO and President, is taking over as the interim principal financial and accounting officer from May 4, 2024, until a permanent replacement is found or until he departs from the role. Yvonne Li steps in as the Interim Chief Financial Officer on the same date, after the filing of the company’s quarterly report. Li’s appointment comes with a consulting agreement that offers her $350 per hour up to $370,000. These strategic appointments aim to strengthen the company’s financial leadership.
For a thorough assessment of SNTI stock, go to TipRanks’ Stock Analysis page.